首页 | 本学科首页   官方微博 | 高级检索  
检索        

过敏性紫癜患儿血清 IL-17与 MMP-9的变化及意义
引用本文:徐丽娟,刘玲,杨艳君,李春珍,刘福娟,张东风.过敏性紫癜患儿血清 IL-17与 MMP-9的变化及意义[J].国际儿科学杂志,2014,0(4):431-433.
作者姓名:徐丽娟  刘玲  杨艳君  李春珍  刘福娟  张东风
作者单位:徐丽娟 (河北省儿童医院肾脏免疫科, 石家庄,050031); 刘玲 (河北省儿童医院肾脏免疫科, 石家庄,050031); 杨艳君 (河北省儿童医院肾脏免疫科, 石家庄,050031); 李春珍 (河北省儿童医院肾脏免疫科, 石家庄,050031); 刘福娟 (河北省儿童医院肾脏免疫科, 石家庄,050031); 张东风 (河北省儿童医院肾脏免疫科, 石家庄,050031);
摘    要:目的:观察过敏性紫癜患儿血清白细胞介素-17(interleukin-17,IL-17)、基质金属蛋白酶-9( matrix metalloproteinase-9,MMP-9)的水平变化及其相关性,进一步探讨两者在过敏性紫癜及紫癜性肾炎中的发病机制。方法采用ELISA法检测74例过敏性紫癜初期患儿和30例健康体检儿童血清IL-17与MMP-9的水平。结果(1)过敏性紫癜组患儿血清 IL-17(86.59±35.50) fg/L ]高于健康对照组(62.38±14.65) fg/L](P<0.01)。(2)过敏性紫癜患儿血清MMP-9(201.82±105.87) pg/L]高于健康对照组(89.27±27.99) pg/L](P<0.01)。(3)密切随访过敏性紫癜组患儿6个月。6个月时,根据是否有肾脏受累分为非紫癜肾组和紫癜肾组,紫癜肾组在病初血清IL-17101.67±39.55] fg/L]高于非紫癜肾组(81.38±32.79) fg/L](P<0.05);紫癜肾组在病初血清MMP-9(249.63±97.57) pg/L]高于非紫癜肾组(185.30±104.39) pg/L](P<0.05)。(4)过敏性紫癜组血清IL-17与MMP-9无相关性(r =0.184,P>0.05)。结论 IL-17与MMP-9均参与过敏性紫癜、紫癜性肾炎的发病过程。

关 键 词:过敏性紫癜  白细胞介素-17  基质金属蛋白酶-9

Changes and significance of serum interleukin-17 and matrix metalloproteinase-9 in children of henoch-schonlein purpura
Xu Lijuan,Liu Ling,Yang Yanjun,Li Chunzhen,Liu Fujuan,Zhang Dongfeng.Changes and significance of serum interleukin-17 and matrix metalloproteinase-9 in children of henoch-schonlein purpura[J].International Journal of Pediatrics,2014,0(4):431-433.
Authors:Xu Lijuan  Liu Ling  Yang Yanjun  Li Chunzhen  Liu Fujuan  Zhang Dongfeng
Institution:(The Children's Hospital of Hebei Province, Shijiazhuang 050031, China)
Abstract:Objective To investigate the chanegs and correla iton between IL-17 and MMP-9 in c hildren of henoch-schonlein purpura,and to explore the pathogenesis of teh IL-17 and MMP-9 in henoch-schonlein pur-pura /henoch-schonlein purpura nephritis.Methods The level of serum IL-17 andMMP-9 in 74 henoch-schon-lein purpura childr en in initial stage and 30 cases of healthy children( control group) were detetced by ELISA. Results (1) The level of plasma IL-17 was significantly higher in children of henoch-schonlein purpura thna tha t foh ealthy control group (86.59 ±35.50) fg/L vs.(62.38 ±14.65)fg/L,P〈0.01].(2) The level of plasma MMP-9 was significantly higher in children of henoch-schonlein pupru ar than that o fhealt hy control group (201.82 ±105.87) fg/L vs(89.27 ±27.99)fg/L,P 〈0.01].(3) Henoch-schonlein purpura children were followed up for6 months,dependin g on whether the kidney was involved,they were devided into non-henoch-schonlein purpura nephritsi grou p nad henoch-s chonlein purpura nephritis group.In initial phase of HSP,the level of plasma IL-17 was significant lyhigher in henoch-schonlein purpura nephritis group than non-henoch-schonlein purpura nephrits group (101.67 ±39.55) fg/L vs.(101.67 ±39.55)fg/L,P〈0.05].The level of p lasma MMP-9 was significantly higher in henoch-schonlein purpura nephritsi group than no n-henoc h-schonlein purpura nephritis group (249.63 ±97.57) Pg/L vs.(185.30 ±104.39) pg/L,P〈0.05 ].(4) IL-17 and MMP-9 correlation aanlysis didn't show sign ificant correlation(r=0.184,P〉0.05).Conclusion IL -17 and MMP-9 are involved in the pathogenesis of henohc-schonlein purpura/henoch-schonlein pur pura nephritis.
Keywords:Henoch-Schonlein purpura  Interleukin-17  Matrix metalloproteinase-9
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号